Inovio Pharmaceuticals

Filed a patent for "kinetic vacuum treatment devices, systems, and methods" on Thu, April 27, 2023

Filed a patent for "methods of treatment of high-grade squamous intraepithelial lesion (hsil)" on Wed, March 1, 2023

Filed a patent for "cancer vaccines and methods of treatment using the same" on Thu, January 12, 2023

Filed a patent for "vacuum-assisted treatment device, and related systems and methods" on Fri, September 16, 2022

Filed a patent for "tert immunogenic compositions and methods of treatment using the same" on Thu, April 13, 2023

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Thu, October 13, 2022

Filed a patent for "compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil)" on Thu, July 27, 2023

Filed a patent for "lassa virus vaccine and uses thereof" on Mon, October 24, 2022

Filed a patent for "methods of treatment of high-grade squamous intraepithelial lesion (hsil)" on Tue, October 25, 2022

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Mon, December 19, 2022

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Wed, February 15, 2023

Filed a patent for "handheld electroporation devices, and related systems and methods" on Thu, January 18, 2024

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Tue, February 28, 2023

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Fri, March 3, 2023

Filed a patent for "vaccines for recurrent respiratory papillomatosis and methods of using the same" on Fri, April 28, 2023

Filed a patent for "combination of novel vaccines against zika virus and dna antibody constructs for use against zika virus" on Thu, April 25, 2024

Filed a patent for "dna antibody constructs for use against hiv" on Thu, April 18, 2024

Filed a patent for "optimized synthetic consensus immunogenic compositions targeting the follicle stimulating hormone receptor (fshr)" on Thu, April 11, 2024

Filed a patent for "dna monoclonal antibodies targeting checkpoint molecules" on Thu, June 13, 2024